These results suggest that YGY decoction effectively counteracts oxidative damage caused by glucocorticoids to achieve therapeutic effects in treating osteonecrosis, which is achieved by modulating the ROS/PHD2/HIF-1α signaling pathway (Fig. 9). This evidence concerns the gene HIF1A and osteonecrosis.